NATCOPHARMstockNatco Pharma Ltd
₹867.1
▲+1.83%
Open
₹852
High
₹869
Low
₹844.05
Volume
678.8K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹1,095.82026-06-18 · ₹882.05
Instrument details
- MB Code
- MBEQU51
- Type
- stock
- ISIN
- INE987B01026
- BSE
- 524816
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 739.1 Cr
- Net profit
- 233.3 Cr
- EPS
- 14.96
- YoY revenue
- -39.47%
Price returns
Historical performance
- 1 day
- +1.72%
- 1 month
- -22.07%
- 3 months
- -7.91%
- 1 year
- +0.51%
- 3 years
- +39.73%
- 5 years
- -19.46%
Technicals
Indicator consensus
Bullish
15
Neutral
5
Bearish
26
RSI 45.05(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
80Investor presentations
82Corporate announcements
280Corporate timeline
Price chart events · 1 year
Dividend
2025-08-19
{"amount":2}
Dividend
2025-11-20
{"amount":1.5}
Dividend
2026-02-18
{"amount":1.5}
Earnings
2026-02-12
{"actualRevenue":6473000000,"estimateRevenue":7489000000,"revenueSurprise":-1016000000,"revenueSurprisePercent":-13.5665642942983,"actualEPS":8.46,"estimateEPS":1.224,"surprise":7.236000000000001,"surprisePercent":591.1764705882354}
Earnings
2025-11-14
{"actualRevenue":13630000000,"estimateRevenue":11725000000,"revenueSurprise":1905000000,"revenueSurprisePercent":16.24733475479744,"actualEPS":28.94,"estimateEPS":25.194,"surprise":3.746000000000002,"surprisePercent":14.86861951258237}
News
2026-05-29
{"description":"Natco Pharma's Q4FY26 net profit fell 34% to ₹269 crore as revenue dropped 39.5% and EBITDA 77%; margins shrank sharply, and the stock sank over 9% to an intraday low of ₹1,060.","url":"https://www.cnbctv18.com/market/natco-pharma-q4-results-stock-falls-as-revenue-drops-40-pc-margin-shrinks-ws-el-19915692.htm","sentiment":"Negative","domain":"cnbctv18"}
News
2026-05-29
{"description":"Natco Pharma shares fell 12% after Q4 net profit dropped 34% to Rs 268 crore, while revenue from operations fell 39.5% to Rs 739 crore from Rs 1,221 crore a year earlier.","url":"https://www.moneycontrol.com/news/business/markets/natco-pharma-shares-fall-11-as-firm-reports-34-drop-in-q4-net-profit-at-rs-268-crore-13935716.html","sentiment":"Negative","domain":"Moneycontrol"}
News
2026-05-29
{"description":"Natco Pharma fell 14% after Q4FY26 results showed net profit and revenue dropping more than 39% year on year, disappointing investors.","url":"https://www.msn.com/en-in/lifestyle/pets-animals/natco-pharma-shares-fall-14-after-net-profit-revenue-drops-over-39/ar-AA24lC2V?ocid=BingNewsVerp","sentiment":"Negative","domain":"NDTV Profit on MSN"}
News
2026-05-29
{"description":"Natco Pharma shares fell up to 14.85% on May 29 after Q4 FY26 profit dropped 34% year-on-year to Rs 269 crore and revenue fell to Rs 816.9 crore, triggering heavy volume selling.","url":"https://www.businesstoday.in/markets/stocks/story/natco-pharma-shares-slump-11-after-q4-results-heres-why-the-stock-is-falling-533935-2026-05-29","sentiment":"Negative","domain":"Business Today"}
News
2026-02-16
{"description":"Feb 16 2026: Natco Pharma jumped 11.24% after CDSCO approved generic Semaglutide injection; company plans India launch in March 2026. Q3 FY26 profit rose 13.9% on 36.3% revenue growth.","url":"https://www.business-standard.com/markets/capital-market-news/natco-pharma-soars-as-cdsco-clears-diabetes-drug-semaglutide-126021600230_1.html","sentiment":"Positive","domain":"Business Standard"}